Pharmaceutical Sector Mixed on Merck
57265
Merck &amp; Co.&#39;s decision to pull its Vioxx anti-arthritis drug from the markets due to severe side effects left pharmaceutical sector mixed Thursday.
444667
Pfizer&#39;s surprise announcement of possible health risks connected with its Celebrex drug pushed stocks lower in heavy trading Friday, renewing investors&#39; concerns over the pharmaceutical sector.
768203
NEW YORK - Stocks were mixed Thursday after Merck & Co. said it would be forced to remove its best-selling Vioxx arthritis drug from the market due to serious health risks...
132890
Rival drug giants Pfizer Inc.  and Merck & Co. Inc.  argued conflicting views of the dangers of their pain relievers on Wednesday to U.S. science advisers weighing the risks of medicines similar to recalled arthritis drug Vioxx.
675656
Now that Merck &amp; Co. has removed its arthritis painkiller Vioxx from the market after tests found that it increased the risk of heart attacks and strokes, its rival Pfizer is taking a surprising stance.
332433
Merck&#39;s (MRK :NYSE - news - research) decision to withdraw its popular arthritis drug Vioxx from the market in late September has raised questions about the process leading up to its regulatory approval in 1999 as well as the importance of subsequent
195535
Merck & Co. MRK.N and two other U.S.  drugmakers posted weak third-quarter results on Thursday, hurt  by intensifying competition and the loss of sales from drugs  found to be potentially dangerous.
51653
TORONTO (CP) - The Toronto stock market posted a small gain Thursday, pushed higher by the gold sector, but drug company Merck &amp; Co.
286537
A battle between insurers and drug companies could determine how many medicines will be available to beneficiaries.
612768
WASHINGTON : Drugs giant Merck and Co.&#39;s shares slumped after the firm revealed civil and criminal investigations into the sale of its pain drug Vioxx.
203704
Investors are wary of putting money  into beaten-down generic-drug stocks amid continued fears of  price competition in the sector and new obstacles from  brand-name drug makers.
158632
When Raymond Gilmartin became chairman of the drug maker Merck, it was close to introducing several new medicines. Now, the company is in crisis.
219736
Two prominent players and widely held stocks in the group, Merck (nyse: MRK - news - people ) and Pfizer (nyse: PFE - news - people ), have been especially battered of late.
4532
Merck &amp; Co. faces a dual threat from health insurers and patients&#39; lawyers, after a US study suggested its Vioxx arthritis drug carries a greater risk than rival medicines.
310914
NEW YORK, December 8  - Merck &amp; Co (MRK.NYS) has guided to lower-than-expected 2005 earnings due to the withdrawal of its blockbuster arthritis drug, Vioxx, and increased generic competition for its cholesterol drug, Zocor.
356950
Consolidation in Europe's drugs   sector gathered steam on Thursday as Germany's Merck unveiled a   $13.3-billion deal to buy Europe's top biotech firm Serono, and   Denmark's Nycomed won the drugs unit of Altana.
552579
Company earned 60 cents a share, down from 83 cents a year earlier; Vioxx linked to heart attacks. NEW YORK  - Merck &amp; Co.